Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing treatments for oncology and hematologic diseases, today announced that a member of senior management will present at the Biotech Showcase™ 2015 Conference taking place January 12-14, 2015, in San Francisco, CA. The presentation will include an overview of the Company’s lead candidate, alvocidib, a multi cyclin-dependent kinase (CDK) inhibitor, expected to enter Phase 3 studies for the treatment of acute myeloid leukemia (AML) in 2H2015.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
